Cathy Bradley, PhD, has spent her career showing how policies made by governments, businesses and insurance companies affect real people seeking cancer care. Now in her new role as deputy director at the University of Colorado Cancer Center, Bradley will bring this perspective to designing research and care that affects patients in Colorado and beyond.
“We are fortunate to have Dr. Bradley,” says Richard Schulick, MD, MBA, director of CU Cancer Center. “Her work means all Coloradans, regardless of geography, income, or ethnicity will have better care and more cost-effective treatments.”
Bradley also is the CU Cancer Center’s associate director of population health sciences and associate dean for research in the Colorado School of Public Health. Her research interests include health disparities due to insurance and socioeconomic status, and the costs and outcomes of cancer and its treatment.
“Being part of an organization focused on a single mission – eliminating cancer and its consequences – is an honor,” says Bradley.
Bradley also recognizes the challenge of bringing together basic scientists, clinicians and population scientists to advance our understanding of cancer, translate understanding into clinical care, and then provide access to those discoveries broadly to the community and individually to the bedside.
“The Cancer Prevention and Control program invests heavily in the state of Colorado,” says Bradley. “One of our major efforts is to target prevention efforts, especially to underserved populations.”
Bradley adds these efforts are already paying off, preventing hundreds of cases of cancer throughout Colorado.
Bradley believes that working with and sharing information with cancer centers in neighboring states makes prevention efforts even more effective. With that in mind, Bradley invited the cancer prevention and control leaders from the NCI-designated cancer centers in the Four Corners region of the United States – Colorado, Arizona, New Mexico, and Utah.
These leaders, with expertise in economics, epidemiology, psychology, chemoprevention, and medicine, met in Denver for a two-day summit to share methods, data, and ideas about how to eliminate cancer in their states. They formed multidisciplinary teams and left the summit with clearly delineated steps for tackling the hardest problems in cancer prevention and control—reaching under-
served populations, delivering care efficiently, and providing state-of-the-art care.
“We face many of the same challenges as our neighboring states,” says Bradley. ”When we share what we’ve learned, we can exponentially improve our prevention and control efforts and reach a broader population, preventing and treating cancer throughout the region.”
Another challenge is increasing access to and enrollment in cancer clinical trials that can often lengthen and improve lives.
“Clinical trials are based on strong evidence that a new treatment could be better than current strategies. We want to make sure that CU Cancer Center clinical trials are available in the Colorado communities where people need care,” Bradley says.
In addition to her work with the CU Cancer Center and the Colorado School of Public Health, Bradley serves on several national committees including the National Academies of Science, Engineering, and Medicine National Cancer Policy Forum and Healthcare System Research & Quality Study Section, Agency for Healthcare Quality & Research and the National Advisory Committee to the Agency for Healthcare Quality & Research.